Gene · 51755
Papers3,441
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 3,441
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CDK7, CDK9, or CDK11 inhibition reduces neutrophil-driven inflammation and tissue damage in experimental autoimmune models. | Cell Commun Signal | 2026 | 42823736 | PubTator, text mining | PubMed |
Bacopa monnieri attenuates Alzheimer's pathology by modulating RNA metabolism, cellular stress responses, and Rho GTPase signaling: Phosphoproteomic insights from a cellular model of Alzheimer's disease. | Neurochem Int | 2026 | 42810623 | PubTator, text mining | PubMed |
| Androgen Receptor-Immune Crosstalk in Metastatic Castration-Resistant Prostate Cancer: From Context-Dependent Remodeling to Biomarker-Guided Translation. | Prostate | 2026 | 42801730 | PubTator, text mining | PubMed |
| Protein Expression Dynamics in Breast Cancer Cells Exposed to Nano-Encapsulated Tarin, the Taro Lectin. | Pharmaceutics | 2026 | 42797298 | PubTator, text mining | PubMed |
| Association of ATM Alterations with Outcomes After 177Lu-PSMA-617 Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer. | J Nucl Med | 2026 | 42785951 | PubTator, text mining | PubMed |
| DNA damage repair gene defects combined predict the efficacy of immune checkpoint inhibitors in metastatic castration-resistant prostate cancer: a retrospective cohort study. | Front Genet | 2026 | 42741774 | PubTator, text mining | PubMed |
| Comprehensive Clinicopathologic, Immunohistochemical, and Genomic Profiling of Sporadic Ampullary Somatostatin-producing D-cell Neuroendocrine Tumors Identifies Recurrent HRAS Hotspot Mutations. | Endocr Pathol | 2026 | 42730891 | PubTator, text mining | PubMed |
| Genome-wide CRISPR screens map synthetic lethal interactions across recurrent cancer driver alterations. | Cell Rep | 2026 | 42726641 | PubTator, text mining | PubMed |
| Ellagic acid and bone health: a systematic review of preclinical studies on its protective role against osteoporosis. | Mol Biol Rep | 2026 | 42700298 | PubTator, text mining | PubMed |
| Cannabidiol alters the epigenome of hormone-dependent prostate cancer cells. | Biomed Pharmacother | 2026 | 42691574 | PubTator, text mining | PubMed |
| CDK12/13 inhibition overcomes platinum resistance by impairing RNA metabolism. | Signal Transduct Target Ther | 2026 | 42686681 | PubTator, text mining | PubMed |
| Patterns of Poly(ADP-Ribose) Polymerase Inhibitor Use and Overall Survival in United States Veterans With Prostate Cancer. | Clin Genitourin Cancer | 2026 | 42660761 | PubTator, text mining | PubMed |
| Discovery of novel dual-target CDK12/PARP1 inhibitors for the treatment of triple-negative breast cancer. | Eur J Med Chem | 2026 | 42632193 | PubTator, text mining | PubMed |
| CDK12/13 Inhibition Induces DNA Hypomethylation and Sensitizes Cancer Cells to Compounds Targeting DNA-PK. | J Cell Mol Med | 2026 | 42625328 | PubTator, text mining | PubMed |
| Expression patterns of potential targets for antibody-directed therapy in metastatic castration-resistant prostate cancer patients. | Eur J Cancer | 2026 | 42623835 | PubTator, text mining | PubMed |
| Synthesis and antitumoral evaluation of 3',4'-unsaturated nucleoside analogues bearing a chlorinated remdesivir-like base. | Bioorg Chem | 2026 | 42607445 | PubTator, text mining | PubMed |
| The phosphoproteome of ovarian carcinoma delineates signaling signatures and potentially druggable targets across histotype stages. | NPJ Precis Oncol | 2026 | 42601376 | PubTator, text mining | PubMed |
| Efficacy of Olaparib Plus Abiraterone for Patients with Metastatic Castration-resistant Prostate Cancer and Single Homologous Recombination Repair Gene Mutations in PROpel. | Eur Urol Oncol | 2026 | 42595654 | PubTator, text mining | PubMed |
| How Often are druggable mutations detectable in Metastatic Castration Resistant Prostate Cancer? | Urol Int | 2026 | 42594033 | PubTator, text mining | PubMed |
| Pan-CDK and PLK1 inhibitors as a novel approach for targeted treatment of adrenocortical carcinomas. | Eur J Endocrinol | 2026 | 42592842 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51755/papers